Rosacea Topical Treatment and Care : From Traditional to New Drug Delivery Systems
Rosacea is a multifactorial chronic inflammatory dermatosis characterized by flushing, nontransient erythema, papules and pustules, telangiectasia, and phymatous alterations accompanied by itching, burning, or stinging, the pathophysiology of which is not yet fully understood. Conventional topical treatments usually show limited efficacy due to the physical barrier property of the skin that hinders skin penetration of the active ingredients, thereby hampering proper drug skin delivery and the respective therapeutic or cosmetic effects. New advances regarding the physiopathological understanding of the disease and the underlying mechanisms suggest the potential of new active ingredients as promising therapeutic and cosmetic approaches to this dermatosis. Additionally, the development of new drug delivery systems for skin delivery, particularly the potential of nanoparticles for the topical treatment and care of rosacea, has been described. Emphasis has been placed on their reduced nanometric size, which contributes to a significant improvement in the attainment of targeted skin drug delivery. In addition to the exposition of the known pathophysiology, epidemiology, diagnosis, and preventive measures, this Review covers the topical approaches used in the control of rosacea, including skin care, cosmetics, and topical therapies, as well as the future perspectives on these strategies.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Molecular pharmaceutics - 20(2023), 8 vom: 07. Aug., Seite 3804-3828 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Paiva-Santos, Ana Cláudia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cosmetic |
|---|
| Anmerkungen: |
Date Completed 08.08.2023 Date Revised 11.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1021/acs.molpharmaceut.3c00324 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359785190 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359785190 | ||
| 003 | DE-627 | ||
| 005 | 20231226081622.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acs.molpharmaceut.3c00324 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1199.xml |
| 035 | |a (DE-627)NLM359785190 | ||
| 035 | |a (NLM)37478169 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Paiva-Santos, Ana Cláudia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rosacea Topical Treatment and Care |b From Traditional to New Drug Delivery Systems |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.08.2023 | ||
| 500 | |a Date Revised 11.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Rosacea is a multifactorial chronic inflammatory dermatosis characterized by flushing, nontransient erythema, papules and pustules, telangiectasia, and phymatous alterations accompanied by itching, burning, or stinging, the pathophysiology of which is not yet fully understood. Conventional topical treatments usually show limited efficacy due to the physical barrier property of the skin that hinders skin penetration of the active ingredients, thereby hampering proper drug skin delivery and the respective therapeutic or cosmetic effects. New advances regarding the physiopathological understanding of the disease and the underlying mechanisms suggest the potential of new active ingredients as promising therapeutic and cosmetic approaches to this dermatosis. Additionally, the development of new drug delivery systems for skin delivery, particularly the potential of nanoparticles for the topical treatment and care of rosacea, has been described. Emphasis has been placed on their reduced nanometric size, which contributes to a significant improvement in the attainment of targeted skin drug delivery. In addition to the exposition of the known pathophysiology, epidemiology, diagnosis, and preventive measures, this Review covers the topical approaches used in the control of rosacea, including skin care, cosmetics, and topical therapies, as well as the future perspectives on these strategies | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cosmetic | |
| 650 | 4 | |a Drug Delivery System | |
| 650 | 4 | |a Nanoparticle | |
| 650 | 4 | |a Rosacea | |
| 650 | 4 | |a Skin | |
| 650 | 4 | |a Therapy | |
| 650 | 7 | |a Dermatologic Agents |2 NLM | |
| 700 | 1 | |a Gonçalves, Tatiana |e verfasserin |4 aut | |
| 700 | 1 | |a Peixoto, Diana |e verfasserin |4 aut | |
| 700 | 1 | |a Pires, Patrícia C |e verfasserin |4 aut | |
| 700 | 1 | |a Velsankar, K |e verfasserin |4 aut | |
| 700 | 1 | |a Jha, Niraj Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Chavda, Vivek P |e verfasserin |4 aut | |
| 700 | 1 | |a Mohammad, Imran Shair |e verfasserin |4 aut | |
| 700 | 1 | |a Cefali, Letícia Caramori |e verfasserin |4 aut | |
| 700 | 1 | |a Mazzola, Priscila Gava |e verfasserin |4 aut | |
| 700 | 1 | |a Mascarenhas-Melo, Filipa |e verfasserin |4 aut | |
| 700 | 1 | |a Veiga, Francisco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular pharmaceutics |d 2004 |g 20(2023), 8 vom: 07. Aug., Seite 3804-3828 |w (DE-627)NLM154556807 |x 1543-8392 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2023 |g number:8 |g day:07 |g month:08 |g pages:3804-3828 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1021/acs.molpharmaceut.3c00324 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2023 |e 8 |b 07 |c 08 |h 3804-3828 | ||